control group:Hydroxychloroquine

2 trials

Sponsors

the Third Xiangya Hospital of Central South University, Shanxi Medical University Second Hospital

Conditions

IgA nephropathysystemic lupus erythematosus

Phase 4

Clinical study on treatment of systemic lupus erythematosus with iguratimod

RecruitingChiCTR2300067695

the Third Xiangya Hospital of Central South Universitysystemic lupus erythematosus

Start: 2020-11-23Updated: 2023-05-15

A multicenter randomized controlled trial of enteric-coated mycophenolate sodium tablets for the treatment of IgA nephropathy.

Active, not recruitingChiCTR2400093530

Shanxi Medical University Second HospitalIgA nephropathy

Start: 2024-12-06Updated: 2024-12-09

Related Papers

Enteric-coated Mycophenolate Sodium plus hydroxychloroquine therApy versus hydroxychloroquine for the Remission of Proteinuria in IgA Nephropathy (EMSAR-IgAN trial): study protocol for a randomised trial

BMJ Open2025-04-011 citations